Additional Information

Description

The ActHIB Haemophilus b Conjugate Vaccine, supplied in single-dose vials with diluent, packaged in boxes containing five units each, serves as a critical defense against Haemophilus influenzae type b (Hib) infection. Administered via injection, this vaccine offers comprehensive protection against Hib, a bacterium known to cause severe and potentially life-threatening illnesses such as meningitis and pneumonia, particularly in infants and young children.

ActHIB is available by prescription only, and it underscores the significance of healthcare provider guidance in its administration, ensuring proper dosage and timing following recommended immunization schedules. Refrigeration is imperative for maintaining the vaccine's stability and efficacy, highlighting the importance of proper storage and handling practices.

Each vial includes the necessary diluent for reconstitution, facilitating accurate dosage preparation before administration. By adhering to vaccination protocols and guidelines, healthcare professionals can effectively protect individuals, especially infants and young children, from the debilitating effects of Hib infection, contributing to improved public health outcomes and overall well-being.